Research
Estimated Savings from Enhanced Opioid Management Controls through 3rd Party Payor Access to the Controlled Substance UR and Evaluation System (CURES)
A new Institute analysis suggests that allowing workers' comp payers access to data from the state's prescription drug monitoring program (CURES) would help reduce inappropriate dispensing of opioids in workers' comp, improving injured worker treatment and saving an estimated $57 million in AY 2011 claim costs.
Current Trends In Compound Drug Use and Costs in California WC
New CWCI research shows compound drugs accounted for a declining share of prescription medications dispensed to California injured workers last year, yet compound drug payments continued to represent a growing percentage of prescription dollars.
Differences in Outcomes for Injured Workers Receiving Physician-Dispensed Repackaged Drugs in the California WC System
New CWCI Research shows California workers' comp claims that involve physician-dispensed repackaged drugs have higher average medical and indemnity payments and more days away from work than comparable claims with no physician-dispensed repackaged drugs.
Use of Network Physicians in California WC, AY 2004-3Q2011 Claims
The latest research on network provider utilization in California workers' compensation shows network physicians delivered nearly 80% of first-year, physician-based outpatient treatment on AY 2010 claims.
Public Self-Insured Claims Experience
California Public Self-Insureds Reported Fewer Claims in 2012, But Claim Costs Remained Near 10-Year High
ICIS Injury Score Card: 2001-2011 Other Injury, Poisoning & Toxic Effect Claims
The latest CWCI Injury Score Card provides detailed data on claims in which the diagnosis falls in the "Other Injury, Poisoning and Toxic Effect category, which comprise 1 out of every 13 California workers' comp claims, but 1 out of every 10 loss dollars."
